The transplantation of genomic-corrected LGMD R1 myogenic cells into a mouse model that was both immune- and CAPN3-deficient resulted in muscle engraftment and the rescue of CAPN3 expression. This evidence concerns the gene CAPN3 and limb-girdle muscular dystrophy.